BOARD OF DIRECTORS
Chief Executive Officer
Terry Weber is a nationally recognized CEO and executive consultant who has transformed the business models of healthcare, retail, and automotive industry giants. Terry is known for being a disruptive leader, building extraordinary, high-performing, high-functioning teams and successfully navigating diverse industry sectors, seamlessly adapting them to the changing landscape of business and technological innovation.
Terry joined Biote to drive permanent industry innovation in the hormone optimization market, addressing the 200 million individuals in the U.S. who suffer from hormone imbalance.
Terry’s team-first focus has consistently resulted in growth, both in the financials of the $100 million to $2.5 billion companies she has led, and in the personal accomplishments of the individuals she has mentored. Her track record of accelerating growth includes Ford Motor Company, Advance Auto, British Petroleum, and Jiffy Lube, where Terry modernized and updated an industry once known for sleepy, regional stores into service-oriented and technology-driven retail chains. She has also worked with major consumer brands including Ann Taylor, Fredericks of Hollywood, Kroger, and Lowes Home Stores, helping them adapt and succeed in an increasingly competitive retail environment forever changed by e-commerce.
Terry was awarded the 50 Fastest-Growing Women-Owned/Led Companies of 2021 by the Women Presidents’ Organization (WPO) in collaboration with JP Morgan Chase Commercial Banking, and named one of PharmaVOICE’s 100 Most Inspiring People of 2021 in the life-sciences industry. Terry is a founding member of PreventiveMedicine.org and a board member of the International Women’s Foundation IWF.org.
Marc Beer brings more than 25 years of development and commercialization experience in biotechnology, pharmaceutical, device, and diagnostics and has served as CEO of Aegerion Pharmaceuticals, Inc. and ViaCell and as a member of the Erytech Pharma Board of Directors.
A member of the Miami University Business Advisory Council, Mark previously served as a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council.
Marc has led several companies through significant capital raises and public offerings, including Renovia, LumeNXT Inc., Origami Surgical, Liftique, and Minerva Neurosciences Inc. His extensive experience as a Founder, CEO, and Chairman in numerous health-related companies makes him an ideal contributor to support Biote’s growth initiatives.
Steven J. Heyer
Steven J. Heyer has over 35 years of experience in the consumer and consumer-related products and services industries, leading a range of companies and brands. Steven has applied his experience and analytical skills in a variety of leadership positions across diverse industry groups, including broadcast media, consumer products, and hotel and leisure companies. Steven served as the Chief Executive Officer and Executive Chairman of Haymaker III until it completed its business combination in May 2022 with Biote.
Steven’s operating experiences span leadership and advisory roles at Outback Steakhouse, Starwood Hotels & Resorts Worldwide, The Coca-Cola Company, Turner Broadcasting System, Inc., Young & Rubicam Advertising Worldwide, and Booz Allen & Hamilton. He has also has extensive board experience, including: Atkins Nutritionals Inc., Lazard Ltd and Lazard Group, WPP Group, Equifax, Omnicare, Inc., Vitrue, Inc., and Internet Security Systems, Inc.
Steven received his B.S. from Cornell University and an M.B.A. from New York University.
Andrew R. Heyer
Andrew R. Heyer is a finance professional with over 40 years of experience investing in the consumer and consumer-related products and services industries, as well as a senior banker in leveraged finance during which time his clients included many large private equity firms. Andrew served as the President and a director of Haymaker III until it completed its business combination with Biote in May 2022.
Currently, Andrew serves as the Chief Executive Officer and Founder of Mistral, a private equity fund manager founded in 2007 that invests in the consumer industry. He has extensive leadership experience, including Trimaran Capital Partners, CIBC World Markets Corp., CIBC Argosy Merchant Banking Funds, Drexel Burnham Lambert Incorporated, and Shearson/American Express.
Andrew currently serves on the boards of Tastemaker Acquisition Corp. and AF Acquisition Corp., and has had previous board experience at The Hain Celestial Group, Inc., Worldwise, Inc., The Lovesac Company, Inc., and Insomnia Cookies.
He received his B.Sc. and M.B.A. from the Wharton School of the University of Pennsylvania, graduating magna cum laude.
At Vector Medical Group, Dana Jacoby leads a team of expert consultants. Her expertise spans numerous medical specialties including gastroenterology, dermatology, orthopedics, oncology, dermatology, and retina. Her consulting work is informed by market data, measurement and analytics, strategy design, implementation, and technology innovation. She has personally consulted with over 75% of all urology practices in the US.
As owner of several companies, Dana has overseen multiple mergers and private equity transactions. Additionally, she’s consulted for up to $1 billion in mergers and acquisitions, making her one of the most sought-after healthcare specialists in the U.S.
Dana has worked for individual providers as well as large corporate healthcare companies including General Electric Healthcare and Johnson & Johnson. At Allergen, a global Pharmaceutical Company, she helped launch Botox in Asia.
In her spare time, Dana is an avid runner and Boston Marathon qualifier and has run 68 marathons, including one in every US state and on every continent except Antarctica.
S. Mark Cone, MD, FACOG
Dr. Cone is a seasoned physician executive with leadership experience in multiple healthcare organizations. He is currently the President of Privia Medical Group Gulf Coast, a 350 provider multi-specialty group serving the Gulf Coast market of Texas, with offices in Houston, Austin and San Antonio. He has been a private practice OB-Gyn for 31 years and delivered over 10,000 babies during his career. He is the Market President for Privia Health, a national physician enablement company, facilitating physicians making the transition from fee for service reimbursement models to value based care and risk bearing products. He is the Vice President of US Women’s Health Alliance, a national organization representing over 5,000 OB-Gyn providers, promoting women’s health and supporting independent OB-Gyn practices. He is Chairman of the Board for Global Women’s Health Providers, a Cedar Gate company focused on OB Bundled Payment programs. He serves on the Board of Directors of BioTe Medical, a Nasdaq company and Chairs the Advisory Board for Fannin Surgicare, an ambulatory Surgery Center. In addition to his passion for patient care and making doctor’s lives better, he enjoys hunting, fishing and college sports. He is a graduate of Texas A&M University and Baylor College of Medicine, where he also did his residency. He is married with three children.
Debby Morris brings over 30 years’ experience in executive leadership in healthcare services as well as other service industries. She most recently served as the Executive Vice President, Chief Financial Officer of Apria Healthcare (Nasdaq:APR), a leading provider of home healthcare equipment and related services in the United States where she lead both financial and operational aspects of the business.
Debby brings a breadth of operational and financial experience in both private and public, national, and multi-national companies including building teams and infrastructure, data analytics, SEC Reporting, BOD governance, Investor Relations, M&A, and leading business transformation as well as leading large corporate transactions including taking Apria public in 2021 and completing the sale of Apria in 2022.
She currently serves as a director for Rexford Industrial and serves on the audit, compensation and nomination and